• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Recent Advances in the Study of 4-bromo-1-(phenylsulfonyl)-1H-indole (CAS: 412048-77-2) in Chemical Biology and Pharmaceutical Research

The compound 4-bromo-1-(phenylsulfonyl)-1H-indole (CAS: 412048-77-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic compound, characterized by its brominated indole core and phenylsulfonyl substituent, serves as a key intermediate in the synthesis of biologically active molecules. Recent studies have explored its role in modulating various biological pathways, particularly in the context of cancer therapeutics and anti-inflammatory agents.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 4-bromo-1-(phenylsulfonyl)-1H-indole exhibits potent inhibitory activity against protein kinases involved in tumor proliferation. The researchers utilized structure-activity relationship (SAR) analysis to optimize the compound's binding affinity, leading to the development of novel derivatives with enhanced selectivity and reduced off-target effects. These findings highlight the compound's potential as a scaffold for designing next-generation kinase inhibitors.

In addition to its anticancer properties, recent investigations have revealed the compound's utility in targeting inflammatory pathways. A study in Bioorganic & Medicinal Chemistry Letters (2024) reported that 4-bromo-1-(phenylsulfonyl)-1H-indole derivatives effectively suppress the production of pro-inflammatory cytokines by inhibiting NF-κB signaling. This discovery opens new avenues for developing anti-inflammatory drugs with improved efficacy and safety profiles.

From a synthetic chemistry perspective, advancements in the preparation of 4-bromo-1-(phenylsulfonyl)-1H-indole have been achieved through innovative catalytic methods. A 2024 paper in Organic Letters described a palladium-catalyzed cross-coupling approach that significantly improves the yield and purity of the compound, facilitating its large-scale production for preclinical studies. This methodological breakthrough is expected to accelerate the compound's adoption in industrial drug development pipelines.

Looking ahead, researchers are focusing on expanding the therapeutic applications of 4-bromo-1-(phenylsulfonyl)-1H-indole through computational drug design and high-throughput screening. Molecular docking studies have identified potential interactions with additional biological targets, suggesting broader pharmacological relevance. Furthermore, ongoing clinical trials evaluating its derivatives for various indications are anticipated to provide critical data on pharmacokinetics and therapeutic efficacy in human subjects.

In conclusion, 4-bromo-1-(phenylsulfonyl)-1H-indole (CAS: 412048-77-2) represents a promising chemical entity with multifaceted applications in medicinal chemistry. The recent research progress underscores its value as both a biological probe and a drug candidate, warranting continued investigation into its mechanism of action and therapeutic potential. Future studies should focus on optimizing its drug-like properties and exploring combination therapies to maximize clinical benefits.

• 177775-88-1(9H-Carbazole, 3-bromo-9-[(4-methylphenyl)sulfonyl]-)
• 1198437-91-0(4-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine)
• 90481-77-9(3-Bromo-1-(p-toluenesulfonyl)indole)
• 40899-71-6(1-(benzenesulfonyl)-1H-indole)
• 16851-84-6(1-(4-Bromophenylsulfonyl)-1H-pyrrole)
• 99655-68-2(3-Bromo-1-(phenylsulfonyl)-1H-indole)
• 118757-11-2(5-Bromo-1-(phenylsulfonyl)indole)
• 89241-42-9(5H-Benzo[b]carbazole, 5-(phenylsulfonyl)-)
• 679794-03-7(6-Bromo-1-(phenylsulfonyl)-1H-indole)
• 96546-77-9(1H-Indole, 5-bromo-1-[(4-methylphenyl)sulfonyl]-)